Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas
<p>Non-Hodgkin's lymphomas (NHLs) are the second fastest growing cancer in terms of incidence and deaths in the United States and Europe. NHLs are a heterogeneous cancer group including several haematological neoplasias with different degree of aggressiveness. In spite of the progresses,...
Saved in:
Main Authors: | Massimo Bortolotti (Author), Letizia Polito (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Cancer Therapy - Peertechz Publications,
2015-03-10.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma
by: Camila Bezerra Melo Figueirêdo, et al.
Published: (2014) -
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
by: Firas Badin, et al.
Published: (2010) -
Rituximab-induced interstitial pneumonitis in patient with non-Hodgkin lymphoma: a clinical case
by: Nikolai A. Ognerubov, et al.
Published: (2022) -
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
by: Natalie S. Grover, et al.
Published: (2015) -
Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey
by: William H. Baer II, et al.
Published: (2014)